Avid Bioservices Inc (CDMO)

[jq1234]

You just don't understand. Bavituximab is NOT a single agent IO drug, there is NO point to compare to other single agent IO drug. Keep doing it just shows lack of basic understanding of drug development!

If you think Bavituximab has a future in combination with Yervoy/Keytruda/Opdivo, compare to other non-single agent IO drugs, like IDO from INCY already had clinical data showing its potential in combination with Yervoy, and many others that NEED to be combined with other drugs with single agent activities - literally there are hundreds if not thousands of drugs claiming they enhance Yervoy/Keytruda/Opdivo in preclinical model! Bavituximab is just one of many with iffy preclinical combo data.